Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,387
Closed -$5.79M 165
2026
Q1
$5.79M Sell
4,387
-310
-7% -$425K 0.96% 30
2025
Q4
$5.03M Buy
4,697
+2
+0% +$2.09K 0.79% 32
2025
Q3
$4.55M Buy
4,695
+1,660
+55% +$1.3M 0.73% 30
2025
Q2
$2.43M Buy
3,035
+5
+0.2% +$3.59K 0.48% 47
2025
Q1
$2.01M Buy
3,030
+826
+37% +$601K 0.39% 53
2024
Q4
$1.53M Buy
2,204
+32
+1% +$23K 0.28% 74
2024
Q3
$1.81M Buy
2,172
+1,278
+143% +$1.14M 0.34% 69
2024
Q2
$914K Buy
+894
New +$859K 0.18% 103

Other funds holding ASML

Strategic Advisors's ASML Position: Q2 2026 in Review

Strategic Advisors sold out of ASML (ASML) in Q2 2026, closing a stake of 4,387 shares — an estimated $5.79M sold.

Strategic Advisors first reported a position in ASML in Q2 2024 and held it in 8 quarters. The position peaked at $5.79M in Q1 2026. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Strategic Advisors reported no remaining ASML position as of Q2 2026 after selling out during the quarter.
  • Strategic Advisors sold 4,387 ASML shares in Q2 2026, an estimated $5.79M.
  • Strategic Advisors first reported a position in ASML in Q2 2024 and held it in 8 quarters.
  • Strategic Advisors's ASML position peaked at $5.79M in Q1 2026.
  • 2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Strategic Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.